跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 61 条关于
“AIRMIX”
全部
61
临床试验
32
药物
4
机构
7
资讯
18
去年
VGXI's Successful FDA Inspection Leads to Client's BLA Approval, Strengthening Position in Plasmid DNA Manufacturing
2年前
Immix Biopharma's NXC-201 Shows Promise as Outpatient CAR-T Therapy in Amyloidosis and Multiple Myeloma
去年
Immix Biopharma's NXC-201 CAR-T Shows Promise in Relapsed/Refractory AL Amyloidosis
去年
Immix Biopharma's NXC-201 Shows Promise in AL Amyloidosis Treatment
去年
Avirmax Biopharma Advances Novel Triple-Gene Therapy for Dry AMD with IND-Enabling Studies
2年前
Immix Biopharma Expands NXC-201 Clinical Trial Sites for AL Amyloidosis
3年前
Immix Biopharma Completes $5 Million Equity Offering to Advance Clinical Programs
去年
Stryker Unveils Artix Thrombectomy System: A Breakthrough in Arterial Blood Clot Treatment
2年前
Immix Biopharma's NXC-201 Receives EU Orphan Drug Designation for Multiple Myeloma
3年前
Nexcella's NXC-201 Shows Promise in Relapsed/Refractory Multiple Myeloma and AL Amyloidosis
第 1 页,共 2 页
上一页
下一页